Bioprocess Technology - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509245196

Publication Date:

September 20, 2024

Pages:

134

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

IT Services [2]

Hardware (Computing & Electronics) [3]

Computing & Electronics [4]

Description:

Bioprocess technology is a very important part of biotechnology that majorly deals with methods combining the whole living substance or its components with nutrients to create special chemicals, biotherapeutics, and reagents.
The global market for Bioprocess Technology was estimated to be worth US$ 10200 million in 2023 and is forecast to a readjusted size of US$ 14680 million by 2030 with a CAGR of 4.9% during the forecast period 2024-2030
North American market for Bioprocess Technology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Bioprocess Technology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Bioprocess Technology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Bioprocess Technology include Merck, Danaher Life Sciences, GE Healthcare, Fujifilm Healthcare, Catalent, Lonza, Colder Products Co., Thermo Fisher Scientific and Sartorius Stedim Biotech, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bioprocess Technology, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Bioprocess Technology by region & country, by Type, and by Application.
The Bioprocess Technology market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bioprocess Technology.
麻豆原创 Segmentation
By Company
Merck
Danaher Life Sciences
GE Healthcare
Fujifilm Healthcare
Catalent
Lonza
Colder Products Co.
Thermo Fisher Scientific
Sartorius Stedim Biotech
Asahi Kasei Medical
Boehringer Ingelheim
Corning
Eppendorf
Repligen
Solesis Medical
Segment by Type:
Biopharmaceuticals
Specialty Products and Industrial Chemicals
Environmental-management Aid
Segment by Application
Research Labs
Medical Institutions
Hospitals
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Bioprocess Technology manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Bioprocess Technology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Bioprocess Technology in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Bioprocess Technology Product Introduction
1.2 Global Bioprocess Technology 麻豆原创 Size Forecast
1.3 Bioprocess Technology 麻豆原创 Trends & Drivers
1.3.1 Bioprocess Technology Industry Trends
1.3.2 Bioprocess Technology 麻豆原创 Drivers & Opportunity
1.3.3 Bioprocess Technology 麻豆原创 Challenges
1.3.4 Bioprocess Technology 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Bioprocess Technology Players Revenue Ranking (2023)
2.2 Global Bioprocess Technology Revenue by Company (2019-2024)
2.3 Key Companies Bioprocess Technology Manufacturing Base Distribution and Headquarters
2.4 Key Companies Bioprocess Technology Product Offered
2.5 Key Companies Time to Begin Mass Production of Bioprocess Technology
2.6 Bioprocess Technology 麻豆原创 Competitive Analysis
2.6.1 Bioprocess Technology 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Bioprocess Technology Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bioprocess Technology as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Biopharmaceuticals
3.1.2 Specialty Products and Industrial Chemicals
3.1.3 Environmental-management Aid
3.2 Global Bioprocess Technology Sales Value by Type
3.2.1 Global Bioprocess Technology Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Bioprocess Technology Sales Value, by Type (2019-2030)
3.2.3 Global Bioprocess Technology Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Research Labs
4.1.2 Medical Institutions
4.1.3 Hospitals
4.1.4 Other
4.2 Global Bioprocess Technology Sales Value by Application
4.2.1 Global Bioprocess Technology Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Bioprocess Technology Sales Value, by Application (2019-2030)
4.2.3 Global Bioprocess Technology Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Bioprocess Technology Sales Value by Region
5.1.1 Global Bioprocess Technology Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Bioprocess Technology Sales Value by Region (2019-2024)
5.1.3 Global Bioprocess Technology Sales Value by Region (2025-2030)
5.1.4 Global Bioprocess Technology Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Bioprocess Technology Sales Value, 2019-2030
5.2.2 North America Bioprocess Technology Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Bioprocess Technology Sales Value, 2019-2030
5.3.2 Europe Bioprocess Technology Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Bioprocess Technology Sales Value, 2019-2030
5.4.2 Asia Pacific Bioprocess Technology Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Bioprocess Technology Sales Value, 2019-2030
5.5.2 South America Bioprocess Technology Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Bioprocess Technology Sales Value, 2019-2030
5.6.2 Middle East & Africa Bioprocess Technology Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Bioprocess Technology Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Bioprocess Technology Sales Value
6.3 United States
6.3.1 United States Bioprocess Technology Sales Value, 2019-2030
6.3.2 United States Bioprocess Technology Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Bioprocess Technology Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Bioprocess Technology Sales Value, 2019-2030
6.4.2 Europe Bioprocess Technology Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Bioprocess Technology Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Bioprocess Technology Sales Value, 2019-2030
6.5.2 China Bioprocess Technology Sales Value by Type (%), 2023 VS 2030
6.5.3 China Bioprocess Technology Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Bioprocess Technology Sales Value, 2019-2030
6.6.2 Japan Bioprocess Technology Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Bioprocess Technology Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Bioprocess Technology Sales Value, 2019-2030
6.7.2 South Korea Bioprocess Technology Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Bioprocess Technology Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Bioprocess Technology Sales Value, 2019-2030
6.8.2 Southeast Asia Bioprocess Technology Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Bioprocess Technology Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Bioprocess Technology Sales Value, 2019-2030
6.9.2 India Bioprocess Technology Sales Value by Type (%), 2023 VS 2030
6.9.3 India Bioprocess Technology Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Merck
7.1.1 Merck Profile
7.1.2 Merck Main Business
7.1.3 Merck Bioprocess Technology Products, Services and Solutions
7.1.4 Merck Bioprocess Technology Revenue (US$ Million) & (2019-2024)
7.1.5 Merck Recent Developments
7.2 Danaher Life Sciences
7.2.1 Danaher Life Sciences Profile
7.2.2 Danaher Life Sciences Main Business
7.2.3 Danaher Life Sciences Bioprocess Technology Products, Services and Solutions
7.2.4 Danaher Life Sciences Bioprocess Technology Revenue (US$ Million) & (2019-2024)
7.2.5 Danaher Life Sciences Recent Developments
7.3 GE Healthcare
7.3.1 GE Healthcare Profile
7.3.2 GE Healthcare Main Business
7.3.3 GE Healthcare Bioprocess Technology Products, Services and Solutions
7.3.4 GE Healthcare Bioprocess Technology Revenue (US$ Million) & (2019-2024)
7.3.5 Fujifilm Healthcare Recent Developments
7.4 Fujifilm Healthcare
7.4.1 Fujifilm Healthcare Profile
7.4.2 Fujifilm Healthcare Main Business
7.4.3 Fujifilm Healthcare Bioprocess Technology Products, Services and Solutions
7.4.4 Fujifilm Healthcare Bioprocess Technology Revenue (US$ Million) & (2019-2024)
7.4.5 Fujifilm Healthcare Recent Developments
7.5 Catalent
7.5.1 Catalent Profile
7.5.2 Catalent Main Business
7.5.3 Catalent Bioprocess Technology Products, Services and Solutions
7.5.4 Catalent Bioprocess Technology Revenue (US$ Million) & (2019-2024)
7.5.5 Catalent Recent Developments
7.6 Lonza
7.6.1 Lonza Profile
7.6.2 Lonza Main Business
7.6.3 Lonza Bioprocess Technology Products, Services and Solutions
7.6.4 Lonza Bioprocess Technology Revenue (US$ Million) & (2019-2024)
7.6.5 Lonza Recent Developments
7.7 Colder Products Co.
7.7.1 Colder Products Co. Profile
7.7.2 Colder Products Co. Main Business
7.7.3 Colder Products Co. Bioprocess Technology Products, Services and Solutions
7.7.4 Colder Products Co. Bioprocess Technology Revenue (US$ Million) & (2019-2024)
7.7.5 Colder Products Co. Recent Developments
7.8 Thermo Fisher Scientific
7.8.1 Thermo Fisher Scientific Profile
7.8.2 Thermo Fisher Scientific Main Business
7.8.3 Thermo Fisher Scientific Bioprocess Technology Products, Services and Solutions
7.8.4 Thermo Fisher Scientific Bioprocess Technology Revenue (US$ Million) & (2019-2024)
7.8.5 Thermo Fisher Scientific Recent Developments
7.9 Sartorius Stedim Biotech
7.9.1 Sartorius Stedim Biotech Profile
7.9.2 Sartorius Stedim Biotech Main Business
7.9.3 Sartorius Stedim Biotech Bioprocess Technology Products, Services and Solutions
7.9.4 Sartorius Stedim Biotech Bioprocess Technology Revenue (US$ Million) & (2019-2024)
7.9.5 Sartorius Stedim Biotech Recent Developments
7.10 Asahi Kasei Medical
7.10.1 Asahi Kasei Medical Profile
7.10.2 Asahi Kasei Medical Main Business
7.10.3 Asahi Kasei Medical Bioprocess Technology Products, Services and Solutions
7.10.4 Asahi Kasei Medical Bioprocess Technology Revenue (US$ Million) & (2019-2024)
7.10.5 Asahi Kasei Medical Recent Developments
7.11 Boehringer Ingelheim
7.11.1 Boehringer Ingelheim Profile
7.11.2 Boehringer Ingelheim Main Business
7.11.3 Boehringer Ingelheim Bioprocess Technology Products, Services and Solutions
7.11.4 Boehringer Ingelheim Bioprocess Technology Revenue (US$ Million) & (2019-2024)
7.11.5 Boehringer Ingelheim Recent Developments
7.12 Corning
7.12.1 Corning Profile
7.12.2 Corning Main Business
7.12.3 Corning Bioprocess Technology Products, Services and Solutions
7.12.4 Corning Bioprocess Technology Revenue (US$ Million) & (2019-2024)
7.12.5 Corning Recent Developments
7.13 Eppendorf
7.13.1 Eppendorf Profile
7.13.2 Eppendorf Main Business
7.13.3 Eppendorf Bioprocess Technology Products, Services and Solutions
7.13.4 Eppendorf Bioprocess Technology Revenue (US$ Million) & (2019-2024)
7.13.5 Eppendorf Recent Developments
7.14 Repligen
7.14.1 Repligen Profile
7.14.2 Repligen Main Business
7.14.3 Repligen Bioprocess Technology Products, Services and Solutions
7.14.4 Repligen Bioprocess Technology Revenue (US$ Million) & (2019-2024)
7.14.5 Repligen Recent Developments
7.15 Solesis Medical
7.15.1 Solesis Medical Profile
7.15.2 Solesis Medical Main Business
7.15.3 Solesis Medical Bioprocess Technology Products, Services and Solutions
7.15.4 Solesis Medical Bioprocess Technology Revenue (US$ Million) & (2019-2024)
7.15.5 Solesis Medical Recent Developments
8 Industry Chain Analysis
8.1 Bioprocess Technology Industrial Chain
8.2 Bioprocess Technology Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Bioprocess Technology Sales Model
8.5.2 Sales Channel
8.5.3 Bioprocess Technology Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Merck
Danaher Life Sciences
GE Healthcare
Fujifilm Healthcare
Catalent
Lonza
Colder Products Co.
Thermo Fisher Scientific
Sartorius Stedim Biotech
Asahi Kasei Medical
Boehringer Ingelheim
Corning
Eppendorf
Repligen
Solesis Medical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.